UBS resumed coverage of KKR with a rating of Buy and set a new price target of $176.00
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/14/2026 | $131.00 | Buy → Hold | TD Cowen |
| 12/11/2025 | $176.00 | Buy | UBS |
| 7/14/2025 | Mkt Outperform → Mkt Perform | Citizens JMP | |
| 7/9/2025 | $142.00 | Buy → Hold | HSBC Securities |
| 6/30/2025 | $150.00 | Overweight | Piper Sandler |
| 5/14/2025 | $150.00 | Equal-Weight → Overweight | Morgan Stanley |
| 4/15/2025 | $119.00 | Hold → Buy | HSBC Securities |
| 3/20/2025 | $150.00 → $141.00 | Equal Weight → Overweight | Wells Fargo |
4 - KKR & Co. Inc. (0001404912) (Reporting)
4 - KKR & Co. Inc. (0001404912) (Issuer)
4 - KKR & Co. Inc. (0001404912) (Issuer)
TD Cowen downgraded KKR from Buy to Hold and set a new price target of $131.00
UBS resumed coverage of KKR with a rating of Buy and set a new price target of $176.00
Citizens JMP downgraded KKR from Mkt Outperform to Mkt Perform
KKR & Co. Inc. (NYSE:KKR) announced today that Robert H. Lewin, Chief Financial Officer, will present at the 2026 UBS Financial Services Conference on Monday, February 9, 2026 at 1:00PM ET. A live webcast of the presentation will be available on the Investor Center section of KKR's website at https://ir.kkr.com/events-presentations/. For those unable to listen to the live webcast, a replay will be available on the website shortly after the event. Any questions regarding the webcast may be addressed to KKR's Investor Relations team at [email protected]. ABOUT KKR KKR is a leading global investment firm that offers alternative asset management as well as capital markets and i
PHILADELPHIA and NEW YORK, Jan. 21, 2026 /PRNewswire/ -- FS KKR Capital Corp. (NYSE:FSK) announced today plans to release its fourth quarter and full year 2025 results after the close of trading on the New York Stock Exchange on Wednesday, February 25, 2026. FSK will host its fourth quarter and full year 2025 results conference call via live webcast on Thursday, February 26, 2026 at 9:00 a.m. (Eastern Time). All interested parties are welcome to participate and can access the live webcast from the For Investors section of FSK's website at www.fskkrcapitalcorp.com under Events
Global investment firm KKR today announced the completion of an additional investment in Sylvan, a world-leading fungal biotechnology company (the "Company"), through funds managed by KKR with participation from new investors and a follow-on investment from existing investor, Novo Holdings, which increased its ownership stake in the Company as part of this round. Following the investment, KKR remains the majority investor in Sylvan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260120305013/en/ Founded in 1932, Sylvan is a world-leading mushroom spawn and fungal biotechnology company. The company seeks to harness the potential
4 - KKR & Co. Inc. (0001404912) (Issuer)
4 - KKR & Co. Inc. (0001404912) (Issuer)
4 - KKR & Co. Inc. (0001404912) (Reporting)
8-K - KKR & Co. Inc. (0001404912) (Filer)
8-K - KKR & Co. Inc. (0001404912) (Filer)
10-Q - KKR & Co. Inc. (0001404912) (Filer)
PHILADELPHIA and NEW YORK, Jan. 21, 2026 /PRNewswire/ -- FS KKR Capital Corp. (NYSE:FSK) announced today plans to release its fourth quarter and full year 2025 results after the close of trading on the New York Stock Exchange on Wednesday, February 25, 2026. FSK will host its fourth quarter and full year 2025 results conference call via live webcast on Thursday, February 26, 2026 at 9:00 a.m. (Eastern Time). All interested parties are welcome to participate and can access the live webcast from the For Investors section of FSK's website at www.fskkrcapitalcorp.com under Events
KKR & Co. Inc. (NYSE:KKR) announced today that it plans to release its financial results for the fourth quarter 2025 on Thursday, February 5, 2026, before the opening of trading on the New York Stock Exchange. A conference call to discuss KKR's financial results will be held on Thursday, February 5, 2026 at 9:00 a.m. ET. The conference call may be accessed by dialing (877) 407-0312 (U.S. callers) or +1 (201) 389-0899 (non-U.S. callers); a pass code is not required. Additionally, the conference call will be broadcast live over the Internet and may be accessed through the Investor Center section of KKR's website at https://ir.kkr.com/events-presentations/. A replay of the live broadcast wil
Transaction marks the largest single asset logistics transaction in South Korea KKR, a leading global investment firm, and its affiliated Korean asset manager, Kreate Asset Management ("Kreate"), today announced the completion of the acquisition of Cheongna Logistics Center, a high-quality logistics facility located in Incheon, invested by funds managed by KKR, through a fund managed by Kreate in Korea. This represents the largest single asset logistics transaction in Korea to date. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251229774474/en/ Completed in 2022, Cheongna Logistics Center is a large-scale, modern 4.6-million
SC 13G/A - KKR & Co. Inc. (0001404912) (Subject)
SC 13G/A - KKR & Co. Inc. (0001404912) (Subject)
SC 13G/A - KKR & Co. Inc. (0001404912) (Subject)
Global investment firm KKR today announced the completion of an additional investment in Sylvan, a world-leading fungal biotechnology company (the "Company"), through funds managed by KKR with participation from new investors and a follow-on investment from existing investor, Novo Holdings, which increased its ownership stake in the Company as part of this round. Following the investment, KKR remains the majority investor in Sylvan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260120305013/en/ Founded in 1932, Sylvan is a world-leading mushroom spawn and fungal biotechnology company. The company seeks to harness the potential
Peak Reinsurance Company Limited ("Peak Re" or the "Company") and KKR, a leading global investment firm, today announced that funds managed by KKR and Quadrantis Capital have entered into definitive agreements to acquire minority stakes in Peak Re via Peak Reinsurance Holdings Limited. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251020924186/en/ Upon completion, KKR and Quadrantis Capital are expected to hold approximately 11.27% and approximately 1.80% of Peak Re's issued share capital, respectively, with the remaining approximately 86.71% continuing to be held by the majority shareholder, Fosun International Limited. Pruden
KKR & Co. Inc. (NYSE:KKR) today announced that Craig Arnold has been appointed to the Board of Directors effective September 23, 2025. His appointment will bring the number of independent directors to eleven out of a total of fifteen Board seats. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250924641078/en/Craig Arnold Mr. Arnold is the former Chairman and Chief Executive Officer of Eaton Corporation, a global intelligent power management company. KKR's other Board members are: Henry Kravis (Co-Founder and Co-Executive Chairman of KKR), George Roberts (Co-Founder and Co-Executive Chairman of KKR), Joseph Bae (Co-Executive Of